Petros Pharmaceuticals, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
PTPI on Nasdaq
Location
1185 Avenue Of The Americas, 3 Rd Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 11/5/2023

Petros Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John D. Shulman Director, 10%+ Owner $19.6M Dec 22, 2021
Wayne R. Walker Director Dec 21, 2023
Bruce Bernstein Director Dec 21, 2023
Fady Boctor Princ. Exec. Officer & Chief Comm. Officer Dec 21, 2023
Andrew Gesek President, Timm Medical May 11, 2021
Mitchell Arnold Vice Pres. of Finance & Chief Acc. Off. Dec 21, 2023
Metuchen Therapeutics, LLC 10%+ Owner Mar 23, 2021
Joshua Silverman Director Dec 21, 2023
Greg Bradley Director Dec 21, 2023

Recent Insider Transactions by Companies or Individuals for Petros Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.